Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Summit Singhaviranon Clear advanced filters

  • Here the authors show that, in mouse tumors, CD8+ T cells with a low-avidity TCR are the mediators of antitumor and immunotherapy responses, in part because T cells with a high-avidity TCR are more exhausted.

    • Summit Singhaviranon
    • Joseph P. Dempsey
    • Pramod K. Srivastava
    ResearchOpen Access
    Nature Immunology
    Volume: 26, P: 240-251